NASDAQ:CDNA
CareDx Stock News
$15.13
-0.500 (-3.20%)
At Close: May 21, 2024
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference
11:00am, Thursday, 30'th Jul 2020
SOUTH SAN FRANCISCO, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinic
3 Artificial Intelligence Stocks With Long-Term Narratives
02:20am, Saturday, 25'th Jul 2020
Artificial intelligence (AI) is a buzzword in tech these days. The term, which encompasses a range of technologies including machine learning and data analysis. The goal is to create systems that can
CareDx Inc (NASDAQ:CDNA) Shares Bought by Tiaa Fsb
08:36am, Friday, 17'th Jul 2020
Tiaa Fsb grew its stake in shares of CareDx Inc (NASDAQ:CDNA) by 4.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 77,491 shares of the company’s stock aft
CareDx to Report Second Quarter 2020 Financial Results
08:05pm, Thursday, 16'th Jul 2020
SOUTH SAN FRANCISCO, Calif., July 16, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx Chairman and CEO Peter Maag to Present at Global Kidney Innovations Summit
11:00am, Wednesday, 15'th Jul 2020
SOUTH SAN FRANCISCO, Calif., July 15, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
AQR Capital Management LLC Sells 38,532 Shares of CareDx Inc (NASDAQ:CDNA)
08:04am, Saturday, 11'th Jul 2020
AQR Capital Management LLC trimmed its position in CareDx Inc (NASDAQ:CDNA) by 75.2% during the first quarter, HoldingsChannel reports. The institutional investor owned 12,706 shares of the company’
Zacks: Brokerages Expect CareDx Inc (NASDAQ:CDNA) Will Post Quarterly Sales of $35.52 Million
02:20am, Saturday, 04'th Jul 2020
Analysts expect CareDx Inc (NASDAQ:CDNA) to post $35.52 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for CareDx’s earnings. The
CareDx’s (CDNA) “Buy” Rating Reaffirmed at Piper Sandler
04:00am, Tuesday, 30'th Jun 2020
Piper Sandler reaffirmed their buy rating on shares of CareDx (NASDAQ:CDNA) in a research note issued to investors on Monday morning, TipRanks reports. The firm currently has a $54.00 target price on
Hedge Funds Aren’t Crazy About CareDx, Inc. (CDNA) Anymore
08:12pm, Wednesday, 24'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
New Kidney360 Publication Highlights CareDx’s AlloSure is Differentiated as the dd-cfDNA Test of Choice
11:00am, Monday, 22'nd Jun 2020
SOUTH SAN FRANCISCO, Calif., June 22, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
Deutsche Bank AG Boosts Stock Position in CareDx Inc (NASDAQ:CDNA)
08:39am, Sunday, 21'st Jun 2020
Deutsche Bank AG increased its holdings in CareDx Inc (NASDAQ:CDNA) by 0.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 237,795 shares of the comp
CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
08:05pm, Thursday, 18'th Jun 2020
The option was granted in connection with the public offering of 3,906,250 shares of common stock at a public offering price of $32.00 per share, which closed on June 15, 2020. After giving effect to
FDA Accepts Letter of Intent for iBox Scoring System as a Surrogate Endpoint in Pharmaceutical Clinical Trials
11:00am, Thursday, 18'th Jun 2020
SOUTH SAN FRANCISCO, Calif., June 18, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.